Quest Diagnostics ROE 2006-2018 | DGX

Current and historical return on equity (ROE) values for Quest Diagnostics (DGX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Quest Diagnostics ROE for the three months ending September 30, 2018 was 15.71%.
Quest Diagnostics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.86B $5.37B 16.66%
2018-06-30 $0.81B $5.26B 16.07%
2018-03-31 $0.78B $5.07B 15.97%
2017-12-31 $0.77B $4.96B 16.04%
2017-09-30 $0.67B $4.83B 14.19%
2017-06-30 $0.70B $4.73B 14.95%
2017-03-31 $0.70B $4.66B 15.13%
2016-12-31 $0.64B $4.66B 13.81%
2016-09-30 $0.68B $4.69B 14.48%
2016-06-30 $0.83B $4.57B 17.77%
2016-03-31 $0.75B $4.67B 16.31%
2015-12-31 $0.71B $4.71B 15.73%
2015-09-30 $0.71B $4.62B 16.19%
2015-06-30 $0.50B $4.34B 11.61%
2015-03-31 $0.51B $4.27B 12.12%
2014-12-31 $0.56B $4.33B 13.33%
2014-09-30 $0.51B $4.21B 12.47%
2014-06-30 $0.79B $4.12B 19.64%
2014-03-31 $0.82B $4.02B 20.68%
2013-12-31 $0.85B $3.97B 21.21%
2013-09-30 $0.76B $3.87B 18.79%
2013-06-30 $0.52B $3.94B 12.57%
2013-03-31 $0.53B $4.23B 12.82%
2012-12-31 $0.56B $4.19B 13.64%
2012-09-30 $0.69B $4.20B 17.44%
2012-06-30 $0.70B $4.02B 18.42%
2012-03-31 $0.68B $3.90B 18.73%
2011-12-31 $0.47B $3.72B 13.51%
2011-09-30 $0.45B $3.55B 12.51%
2011-06-30 $0.47B $3.45B 12.94%
2011-03-31 $0.51B $3.24B 13.36%
2010-12-31 $0.72B $4.05B 18.24%
2010-09-30 $0.74B $3.88B 18.70%
2010-06-30 $0.73B $3.95B 18.48%
2010-03-31 $0.72B $3.93B 18.51%
2009-12-31 $0.73B $4.01B 19.13%
2009-09-30 $0.72B $3.94B 19.30%
2009-06-30 $0.64B $3.77B 17.36%
2009-03-31 $0.61B $3.53B 16.73%
2008-12-31 $0.58B $3.63B 16.03%
2008-09-30 $0.41B $3.73B 11.44%
2008-06-30 $0.39B $3.67B 11.40%
2008-03-31 $0.37B $3.50B 11.21%
2007-12-31 $0.34B $3.32B 10.57%
2007-09-30 $0.49B $3.33B 15.73%
2007-06-30 $0.56B $3.19B 18.10%
2007-03-31 $0.55B $3.03B 18.24%
2006-12-31 $0.59B $3.02B 19.80%
2006-09-30 $0.57B $3.07B 19.59%
2006-06-30 $0.54B $2.90B 19.09%
2006-03-31 $0.56B $2.87B 19.90%
2005-12-31 $0.55B $2.76B 19.84%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.826B $7.709B
Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
Stock Name Country Market Cap PE Ratio
Elanco Animal Health (ELAN) United States $12.358B 0.00
DaVita (DVA) United States $10.035B 16.89
Encompass Health (EHC) United States $7.095B 20.32
Chemed (CHE) United States $4.968B 27.31
Amedisys (AMED) United States $3.879B 36.86
LHC Group (LHCG) United States $3.009B 31.55
U.S Physical Therapy (USPH) United States $1.458B 47.50
Addus HomeCare (ADUS) United States $0.910B 42.90
Hanger (HNGR) United States $0.700B 7.06
RadNet (RDNT) United States $0.631B 40.38
American Renal Associates Holdings (ARA) United States $0.521B 23.56
BioScrip (BIOS) United States $0.407B 0.00
Catasys (CATS) United States $0.160B 0.00
Quorum Health (QHC) United States $0.130B 0.00
Psychemedics (PMD) United States $0.098B 19.94
AAC Holdings (AAC) United States $0.048B 8.21
Daxor (DXR) United States $0.024B 0.00
Helios And Matheson Analytics Inc (HMNY) United States $0.010B 0.00